Review



mouse anti mouse c5  (Hycult Biotech)


Bioz Verified Symbol Hycult Biotech is a verified supplier
Bioz Manufacturer Symbol Hycult Biotech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Hycult Biotech mouse anti mouse c5
    Summary of antibodies used for immunohistochemistry
    Mouse Anti Mouse C5, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti mouse c5/product/Hycult Biotech
    Average 91 stars, based on 1 article reviews
    mouse anti mouse c5 - by Bioz Stars, 2025-02
    91/100 stars

    Images

    1) Product Images from "Dysregulation of the complement cascade in the hSOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis"

    Article Title: Dysregulation of the complement cascade in the hSOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis

    Journal: Journal of Neuroinflammation

    doi: 10.1186/1742-2094-10-119

    Summary of antibodies used for immunohistochemistry
    Figure Legend Snippet: Summary of antibodies used for immunohistochemistry

    Techniques Used:

    Expression and localisation of C5 and C5a in hSOD1 G93A and wild-type mice during disease progression. (A) mRNA expression profile of C5 in lumbar spinal cord of hSOD1 G93A mice relative to wild-type (WT) mice. Dashed line, baseline expression in WT controls at each time point. (B) Protein expression of C5a in the lumbar spinal cord of hSOD1 G93A mice has decreased by end stage (ES) when compared with WT mice. (A , B) Data expressed as mean ± standard error of the mean ( n = 6 mice/group; * P <0.05, Student t test). (C) to (H) Double immunolabelling for C5 (red) with cellular makers (green) for motor neurons (ChAT; C and D , arrows), astrocytes (g lial fibrillary acidic protein (GFAP), E and F ), and microglia (CD11b; G and H ), in the ventral lumbar spinal cord region of hSOD1 G93A mice (D , F and H) and WT mice (C , E and G) at end stage. Co-localisation of C5 with these cellular markers is seen as a merge of green and red ( for example, white arrows in C , D , and H) . PS, pre-symptomatic; OS, onset; MS, mid-symptomatic; ES, end-stage. Scale bar for C to H = 20 μm.
    Figure Legend Snippet: Expression and localisation of C5 and C5a in hSOD1 G93A and wild-type mice during disease progression. (A) mRNA expression profile of C5 in lumbar spinal cord of hSOD1 G93A mice relative to wild-type (WT) mice. Dashed line, baseline expression in WT controls at each time point. (B) Protein expression of C5a in the lumbar spinal cord of hSOD1 G93A mice has decreased by end stage (ES) when compared with WT mice. (A , B) Data expressed as mean ± standard error of the mean ( n = 6 mice/group; * P <0.05, Student t test). (C) to (H) Double immunolabelling for C5 (red) with cellular makers (green) for motor neurons (ChAT; C and D , arrows), astrocytes (g lial fibrillary acidic protein (GFAP), E and F ), and microglia (CD11b; G and H ), in the ventral lumbar spinal cord region of hSOD1 G93A mice (D , F and H) and WT mice (C , E and G) at end stage. Co-localisation of C5 with these cellular markers is seen as a merge of green and red ( for example, white arrows in C , D , and H) . PS, pre-symptomatic; OS, onset; MS, mid-symptomatic; ES, end-stage. Scale bar for C to H = 20 μm.

    Techniques Used: Expressing



    Similar Products

    91
    Hycult Biotech mouse anti mouse c5
    Summary of antibodies used for immunohistochemistry
    Mouse Anti Mouse C5, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti mouse c5/product/Hycult Biotech
    Average 91 stars, based on 1 article reviews
    mouse anti mouse c5 - by Bioz Stars, 2025-02
    91/100 stars
      Buy from Supplier

    Image Search Results


    Summary of antibodies used for immunohistochemistry

    Journal: Journal of Neuroinflammation

    Article Title: Dysregulation of the complement cascade in the hSOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis

    doi: 10.1186/1742-2094-10-119

    Figure Lengend Snippet: Summary of antibodies used for immunohistochemistry

    Article Snippet: Mouse anti-mouse C5 , Hycult Biotechnology 1 , 1:1,000 , GFAP, CD11b, ChAT.

    Techniques:

    Expression and localisation of C5 and C5a in hSOD1 G93A and wild-type mice during disease progression. (A) mRNA expression profile of C5 in lumbar spinal cord of hSOD1 G93A mice relative to wild-type (WT) mice. Dashed line, baseline expression in WT controls at each time point. (B) Protein expression of C5a in the lumbar spinal cord of hSOD1 G93A mice has decreased by end stage (ES) when compared with WT mice. (A , B) Data expressed as mean ± standard error of the mean ( n = 6 mice/group; * P <0.05, Student t test). (C) to (H) Double immunolabelling for C5 (red) with cellular makers (green) for motor neurons (ChAT; C and D , arrows), astrocytes (g lial fibrillary acidic protein (GFAP), E and F ), and microglia (CD11b; G and H ), in the ventral lumbar spinal cord region of hSOD1 G93A mice (D , F and H) and WT mice (C , E and G) at end stage. Co-localisation of C5 with these cellular markers is seen as a merge of green and red ( for example, white arrows in C , D , and H) . PS, pre-symptomatic; OS, onset; MS, mid-symptomatic; ES, end-stage. Scale bar for C to H = 20 μm.

    Journal: Journal of Neuroinflammation

    Article Title: Dysregulation of the complement cascade in the hSOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis

    doi: 10.1186/1742-2094-10-119

    Figure Lengend Snippet: Expression and localisation of C5 and C5a in hSOD1 G93A and wild-type mice during disease progression. (A) mRNA expression profile of C5 in lumbar spinal cord of hSOD1 G93A mice relative to wild-type (WT) mice. Dashed line, baseline expression in WT controls at each time point. (B) Protein expression of C5a in the lumbar spinal cord of hSOD1 G93A mice has decreased by end stage (ES) when compared with WT mice. (A , B) Data expressed as mean ± standard error of the mean ( n = 6 mice/group; * P <0.05, Student t test). (C) to (H) Double immunolabelling for C5 (red) with cellular makers (green) for motor neurons (ChAT; C and D , arrows), astrocytes (g lial fibrillary acidic protein (GFAP), E and F ), and microglia (CD11b; G and H ), in the ventral lumbar spinal cord region of hSOD1 G93A mice (D , F and H) and WT mice (C , E and G) at end stage. Co-localisation of C5 with these cellular markers is seen as a merge of green and red ( for example, white arrows in C , D , and H) . PS, pre-symptomatic; OS, onset; MS, mid-symptomatic; ES, end-stage. Scale bar for C to H = 20 μm.

    Article Snippet: Mouse anti-mouse C5 , Hycult Biotechnology 1 , 1:1,000 , GFAP, CD11b, ChAT.

    Techniques: Expressing